| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INDIRECT ACCOUNTING FEES | 1,175 | 1,175 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| HARPOON THERAPEUTICS | 2020-02 | PURCHASE | 2024-03 | 230 | 1,450 | -1,220 | ||||
| HIRERIGHT HOLDINGS CO | 2022-05 | PURCHASE | 2024-06 | 1,435 | 1,550 | -115 | ||||
| META PLATFORMS INC | 2019-04 | PURCHASE | 2024-07 | 4,766 | 1,827 | 2,939 | ||||
| NVIDIA CORP | 2020-02 | PURCHASE | 2024-07 | 6,053 | 317 | 5,736 | ||||
| VERTIV HOLDINGS CO | 2020-11 | PURCHASE | 2024-07 | 4,121 | 930 | 3,191 | ||||
| ZIFF DAVIS INC | 2019-10 | PURCHASE | 2024-06 | 2,758 | 3,832 | -1,074 | ||||
| ATRECA INC - EXCHANGE | PURCHASE | 2024-12 | 8 | 2,734 | -2,726 | |||||
| Q32 BIO INC | 2020-02 | PURCHASE | 2024-03 | 2 | 36 | -34 | ||||
| SERINA THERAPEUTICS | 2018-11 | PURCHASE | 2024-03 | 5 | 31 | -26 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| SCHWAB 1119 | 252,093 | 228,698 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| SCHWAB - ETF | AT COST | 4,428 | 4,678 |
| SCHWAB - OTHER ASSETS | AT COST | 10,621 | 7,326 |
| Description | Amount |
|---|---|
| SCHWAB ADJ | 311 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| CASH OVERDRAFT |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 162 | 162 | ||
| FORM 4720 TAX | 600 |